Publicacións en colaboración con investigadores/as de Universitat Pompeu Fabra (5)

2023

  1. Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial

    Therapeutic Advances in Medical Oncology, Vol. 15

2022

  1. BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up

    European Urology

2019

  1. CDK4/6 inhibitor as a novel therapeutic approach for advanced bladder cancer independently of RB1 status

    Clinical Cancer Research, Vol. 25, Núm. 1, pp. 390-402

2015

  1. NOTCH pathway inactivation promotes bladder cancer progression

    Journal of Clinical Investigation, Vol. 125, Núm. 2, pp. 824-830

  2. PIK3CA gene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumors

    Molecular Carcinogenesis, Vol. 54, Núm. 7, pp. 566-576